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Abstract
Objective: the aim of the study was to assess the relationship between depression and diabetic complications 
among urban south Indian type 2 diabetic subjects [t2DM].
Methods: t2DM subjects [n= 847] were recruited from the chennai Urban rural epidemiology Study [cUreS], 
a population based study in chennai (formerly Madras) in South India. A previously validated depression 
questionnaire [PHQ-12 item] was administered. Four field stereo retinal colour photography was done and 
diabetic retinopathy [Dr] was classified according to the early treatment Diabetic retinopathy Study grading 
system. Neuropathy was diagnosed if the vibratory perception threshold of the right great toe, measured by 
biothesiometry, was ≥20. Nephropathy was diagnosed if urinary albumin excretion was ≥300 mg/mg creatinine. 
Peripheral vascular disease [PVD] was diagnosed if an ankle-brachial index was <0.9. coronary artery disease 
[cAD] was diagnosed based on a past history of documented myocardial infarction and/or electrocardiographic 
evidence of Q wave and/or St segment changes. 
Results: of the 847 t2DM studied, 198 (23.4%) were found have depression. the prevalence of depression was 
significantly higher among diabetic subjects with Dr (35.0% vs 21.1%,p<0.001), neuropathy (28.4% vs15.9%,p=0.023), 
nephropathy (35.6% vs 24.5%,p=0.04) and PVD (48.0% vs 27.4%,p<0.001) as compared to subjects without these 
complications. Dr, neuropathy, nephropathy, and PVD were associated with depression even after adjusting 
for age, gender, duration of diabetes and glycated haemoglobin. Dr (odds ratio [or] =2.19, confidence interval 
[cI]:1.45-3.51,p<0.001) was associated with depression even after adjusting for neuropathy and nephropathy. 
there was also a significant association between depression and neuropathy, after adjusting for retinopathy and 
nephropathy (or=2.07,cI:1.41-3.04,p<0.001). there was a significant association of depression with nephropathy 
but this was lost (or=1.71, cI: 0.87-3.35,p=0.119) after adjustment for retinopathy. PVD (or=3.52,cI:1.94-
6.40,p<0.001) remained significantly associated with depression even after adjusting for cAD. However, there 
was no significant association of depression with cAD (or=0.73, cI:0.42 -1.27, p=0.264).
Conclusion: Among Asian Indians, the prevalence of depression is higher in t2DM subjects with retinopathy, 
neuropathy, nephropathy and PVD compared to those without the respective complications.
Introduction
Depression is twice as common in patients with diabetes as in the general population, and its prevalence appears 
to increase with the number of diabetic complications.1 earlier 
studies have examined the association of depression with 
micro- and macrovascular complications of diabetes and there 
is evidence to suggest that the long-term complications of 
diabetes are associated with depressive symptoms.2,3 A meta-
analysis of 27 studies conducted by de Groot et al2 to determine 
whether an association existed between depression and diabetes 
complications reported that depression was associated with 
retinopathy, neuropathy, nephropathy and macrovascular 
disease. 
there is limited data on depression in relation to diabetic 
complications from India, which has over 50 million people 
with diabetes.4 Hence this study was undertaken to examine 
the association between depression and diabetes related 
complications in an urban south Indian population.
Subjects and Methods
the chennai Urban rural epidemiology Study (cUreS) 
is a large ongoing epidemiological study conducted on a 
representative population of chennai using systematic random 
sampling . the details of the sampling and methods of the study 
are published elsewhere.5,6
Briefly, in Phase I, 26,001 subjects were randomly selected 
from 46 of 155 corporation wards of chennai. Self reported type 
2 diabetes was diagnosed if subjects gave a history of diabetes 
diagnosed by a physician and/or if they were on treatment with 
anti-diabetic drugs. These individuals were classified as ‘known 
diabetic subjects (KD).
In Phase II, all the known diabetic (KD) subjects (n=1529) 
identified in Phase I of the study, and those who were diagnosed 
to have diabetes on screening with an oral glucose tolerance test 
(oGtt), termed as newly detected diabetes (NDD) (n=371) were 
invited to Dr.Mohan’s Diabetes Specialties centre, a tertiary 
referral centre for diabetes for detailed studies on various 
vascular complications. In a subset of 900, randomly selected 
t2DM (KD and NDD) subjects a depression questionnaire was 
administered. The Institutional ethics committee approval was 
obtained for the study and informed consent was obtained from 
all the study subjects.
For this study, a total of 847 (response rate:94%) t2 DM (KD: 
579 and NDD: 268), who had information on all test parameters 
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[gradable retinal photographs, biothesiometry, ecG and doppler 
studies and microalbuminuria estimations] and who had 
completed PHQ 12 item questionnaire were included.
Anthropometric measurements including weight, height, 
waist and hip measurements were obtained using standardized 
techniques.5 the body mass index (bMI) was calculated using 
the formula: weight (kg) / height (m2). 
Blood pressure was recorded in the sitting position in the right 
arm using the mercury sphygmomanometer (Diamond Deluxe 
blood Pressure apparatus, Pune, India). blood pressure readings 
were recorded to the nearest 2mm Hg from the top of the mercury 
meniscus. Systolic pressure was recorded at the first appearance 
of sound and diastolic pressure at the disappearance of the sound 
(Korotkoff’s phase V). A mean of two readings taken 5 minutes 
apart was recorded as the blood pressure. Hypertension was 
diagnosed in subjects who were on antihypertensive medication 
or had a systolic bP ≥140 mmHg or diastolic bP ≥90 mmHg.7
the fasting blood sample was taken, after ensuring 8 hours 
of overnight fasting, for estimation of plasma glucose and serum 
lipids using a Hitachi 912 Autoanalyser (roche Diagnostics 
GmbH, Mannheim, Germany) utilizing kits supplied by 
boehringer Mannheim (Mannheim, Germany). Fasting and 
2 hour plasma glucose estimations were done by the glucose 
oxidase method. Glycated hemoglobin (HbA1c) was estimated 
by the high pressure liquid chromatography using the Variant 
machine (bIorAD, Hercules, california,USA). Serum cholesterol 
and serum triglycerides were measured by cHoD-PAP method 
and GPo-PAP method respectively. High-density lipoprotein 
(HDL) cholesterol was estimated by the cHoD-PAP method 
after precipitating low-density lipoprotein and chylomicron 
fractions by the addition of phosphotungstic acid in the presence 
of magnesium ions and very low-density lipoprotein. Low 
density lipoprotein (LDL) cholesterol was calculated using the 
Friedewald formula.
Urine samples were collected after an overnight fast. 
Microalbumin concentration was measured using an 
immunoturbidometric assay (Hitachi 902 autoanalyser, roche 
Diagnostics, Mannheim, Germany). Subjects in whom the 
microalbumin level was above the upper limit of detection (>450 
mg/l) were assigned a value of 450 mg/l. the diagnostic criterion 
for macroalbuminuria or overt nephropathy was albumin 
excretion ≥300 mg/mg of creatinine.8
the ocular fundi were photographed using four-field 
stereo color retinal photography [Zeiss FF 450 plus camera] by 
trained and certified retinal photographers as described earlier.9 
Photographs were graded by an ophthalmologist using the early 
treatment Diabetic retinopathy Study [etDrS] grading system.10 
the minimum criterion for diagnosis of Dr was the presence of at 
least one definite microaneurysm in any field. Briefly, according 
to the etDrS grading, level 10 represents no retinopathy, level 
≥20 non-proliferative Dr (NPDr) and level ≥ 60, proliferative 
Dr (PDr).10 Diabetic Macular Edema (DME) was defined as 
retinal thickening at or within 1 disc diameter of the center of 
the macula or the presence of definite hard exudates.
resting twelve-lead electrocardiogram (ecG) was performed 
using Myocard r electrocardiograph (Marks electronics, 
chennai, India). cAD was diagnosed based on positive medical 
history (documented myocardial infarction (MI), angina pectoris 
and coronary artery bypass graft) and/or ischemic changes 
on a conventional 12-lead ecG which included St-segment 
depression (Minnesota codes 1-1-1 to 1-1-7) or Q-wave changes 
(Minnesota codes 4-1 to 4-2).5   
Doppler studies were performed by a single observer, which 
included recording of pressure tracings using the KoDY Vaslab 
Machine (Kody Labs, chennai, India). the ankle/brachial 
pressure index (AbI) was calculated in every subject. An AbI of 
less than 0.9 was the criteria used for the diagnosis of peripheral 
vascular disease.11
A biothesiometer (biomedical Instrument co., Newbury, 
ohio, USA) was used to assess vibratory perception threshold 
(VPt) of the great toes in a standardized fashion. Neuropathy 
was diagnosed if VPt of the great toe exceeded mean +2 SD of 
healthy non-diabetic study population aged 20-45 years (cut 
point ≥20V).6
A modified version of the Patient Health Questionnaire 
(PHQ)- 9 item was used to assess depression. It was modified 
for local conditions into a 12 item questionnaire (PHQ-12 item 
as previously described.12 The modified -12 item was developed 
with yes or no response by using the same version of PHQ-9 item; 
however, three of the questions in the PHQ-9 item were split 
into two thus accounting for 12 items. the response categories 
were also made dichotomous (yes/no), such that the subject 
would be asked whether they had any of the twelve depressive 
symptoms and, if yes, their frequency, during the pervious two 
weeks would be recorded. The modified PHQ-12 item was then 
validated and shown to be a reliable instrument for screening of 
depression in the general population with a score > 4 being the 
best to identify depression in south Indian population.12 It took 
10 minutes to administer the questionnaire.
Statistical Analysis
All statistical analyses were performed using SAS statistical 
package (version 9.0; SAS Institute, Inc., cary, Nc). Numbers 
are expressed as mean ± standard deviation. Student’s “t” test 
was used to compare groups for continuous variables. chi 
square test was used to compare proportions among groups. 
Logistic regression model was used to determine whether age, 
gender, duration of diabetes and glycated haemoglobin were 
independently associated with depression and its complications. 
For all statistical tests, p value <0.05 was considered as the level 
of significance.
Results
of the 847 type 2 subjects included in this study, (KD: 579 
(68.4%) and ND: 268 (31.6%), depression was seen in 198 subjects 
(23.4%). table 1 depicts the characteristics of diabetic subjects 
with and without depression. Subjects without depression were 
older (51.5 ± 10.8 years) compared to those with depression (49.1 
± 12.2 years) [p=0.009]. None of the other characteristics were 
significantly different between the two groups.
Figure 1 presents the prevalence of depression among 
subjects with and without diabetic complications. Prevalence 
of depression was higher in subjects with retinopathy (35%) 
compared to subjects without Dr (21.1%, p<0.001). In addition, 
when analyzed with respect to severity of diabetic retinopathy, 
the prevalence of depression was highest among subjects with 
proliferative diabetic retinopathy [PDr] (39.1%) followed by 
those with non proliferative diabetic retinopathy [NPDr] (33%) 
and lowest among subjects without diabetic retinopathy (21.1%) 
and the trend was significant [Trend chi c2: 12.263, p =0.002]. the 
prevalence of depression in subjects with neuropathy (28.4% 
vs 21.1%, p=0.023] and nephropathy (35.6% vs 22.7%, p=0.0.04) 
was also significantly higher compared to subjects without these 
respective complications. Prevalence of depression in subjects 
with PVD was significantly higher compared to those subjects 
without PVD (48% vs 21.8%, p<0.001).
Figure 2 presents the prevalence of depression in relation 
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to the number of diabetic complications. the prevalence of 
depression in subjects without any complication was 16.2% 
and in those with one complication it was 29.2%, while in those 
with two or more complications, it was 33.1% [trend chi c2: 
22.43, p<0.001].
to evaluate the association of depression with various 
complications, models were developed based on logistic 
regression using depression as the dependent variable. Various 
factors associated with microvascular complications were first 
included as independent variable and later the complications 
themselves were included in the model (table 2). Depression 
was significantly associated with retinopathy even after adjusting 
for age, gender, glycated haemoglobin, duration of diabetes, 
neuropathy and nephropathy. (or=2.19, cI: 1.45-3.51, p<0.001). 
There was significant association of depression with neuropathy 
even after adjusting for age, gender, glycated haemoglobin, 
duration of diabetes, retinopathy and nephropathy (or=2.07, 
cI: 1.41-3.04, p<0.001). there was an association of depression 
with nephropathy but the association was lost after adjusting 
for retinopathy (or=1.71, cI: 0.87-3.35, p=0.119).
Depression was significantly associated with peripheral 
Table 1: General characteristics of diabetic subjects with and 
without depression 
Variables
Diabetic Subjects
p ValueWithout 
Depression
( n=649 )
With Depression
(n=198)
Age (years) 51.5±10.8 49.1±12.2 0.009
Male n (%) 303(46.7) 80(40.4) 0.122
Waist (cms) 91±10 89.3±10.2 0.057
Hip (cms) 98±10 97±11 0.264
Height (cms) 158±9 157±9 0.129
Weight (kg) 63.4±11.3 61.5±12.2 0.043
body mass index 
(kg/m2)
25.3±4.1 24.9±4.5 0.215
Fasting blood 
sugar (mg/dl)
159.8±63.9 160.3±71.7 0.943
Duration of 
diabetes (Years)*
4.4 ± 0.2 4.6 ± 0.4 0.687
HbA1c % 8.6±2.1 8.6±2.2 0.869
Serum 
cholesterol(mg/dl)
199±41 203 ±43 0.300
Serum 
triglycerides(mg/
dl)**
151.5±5.1 156.7±9.8 0.093
Serum HDL 
cholesterol(mg/dl)
42.4±8.9 43.6±9.5 0.922
Serum LDL 
cholesterol (mg/dl)
124.3±33.7 124.6±34.0 0.928
creatinine (mg/dl) 0.9±0.2 0.9±0.2 0.118
Smoking n (%) 109 (16.8) 39 (19.7) 0.338
Alcohol n (%) 124 (19.1) 41 (20.7) 0.610
Data presented as mean ± standard deviation (S.D) or number (%) 
subjects; *Standard error of mean (SeM); **Geometric mean
Fig. 1 : Prevalence of depression in relation to diabetic 
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Fig. 2: Prevalence of depression in relation to number of diabetic 
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Table 2: Association of depression with microvascular 
complications of diabetes
Variables Odds ratio 95% confidence interval p value
Retinopathy (No =0, Yes = 1)
Model 1: Unadjusted 2.017 1.363- 2.983 <0.001
Model 2 :Model 1 + age 2.226 1.492-3.321 <0.001
Model 3 :Model 2 + gender 2.289 1.530-3.424 <0.001
Model 4: Model 3 + HbA1c 2.373 1.571-3.583 <0.001
Model 5: Model 4 + duration 
of diabetes
2.266 1.483-3.464 <0.001
Model 6: Model 5 + 
neuropathy
2.285 1.488-3.507 <0.001
Model 7: Model 6 + 
nephropathy
2.185 1.417-3.371 <0.001
Neuropathy (No =0, Yes = 1)
Model 1: Unadjusted 1.483 1.064-2.067 0.020
Model 2: Model 1 + age 2.074 1.424-3.023 <0.001
Model 3: Model 2+gender 2.052 1.407-2.992 <0.001
Model 4: Model 3+ HbA1c 2.059 1.412-3.004 <0.001
Model 5: Model 4 + duration 
of diabetes
2.060 1.411-3.007 <0.001
Model 6:Model 5 + 
retinopathy
2.071 1.415-3.031 <0.001
Model 7:Model 6 + 
nephropathy
2.072 1.414-3.035  <0.001
Nephropathy (No =0, Yes = 1)
Model 1: Unadjusted 1.879 0.999-3.537 0.050
Model 2: Model 1 + age 2.017 1.066-3.818 0.031
Model 3: Model 2+gender 2.018 1.066-3.818 0.031
Model 4: Model 3+ HbA1c 2.069 1.083-3.956   0.028
Model 5: Model 4 + duration 
of diabetes
1.973 1.029-3.784  0.041
Model 6: Model 5 + 
neuropathy
2.007 1.040-3.873 0.038
Model 7: Model 6 + 
retinopathy
1.708 0.872-3.345 0.119
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vascular disease (PVD) in the unadjusted model (or: 3.305, 95% 
cI: 1.851-5.901, p <0.001), and the which retained significance 
was retained even after adjusting for age, gender, glycated 
hemoglobin duration of diabetes and cAD (or= 3.52, cI: 
1.94-6.40, p<0.001). There was no significant association with 
depression and cAD (or= 0.73, cI: 0.42 -1.27, p = 0.264) (table 3). 
Discussion
In this study, we report that the prevalence of depression is 
higher among t2 DM subjects with retinopathy, neuropathy, 
nephropathy and PVD. biological, psychological or behavioral 
responses to stressors facing patients with diabetes may all play 
a role in increasing the prevalence of depression in patients 
with diabetes.2 Functional impairment in diabetic patients 
with neuropathy or retinopathy, may also increase prevalence 
of depression as shown by the increasing depression with 
increasing severity of retinopathy in our study.
conversely, it has been reported that individuals with 
depression are at increased risk of developing clinically 
significant micro and or macro vascular complications of 
diabetes.2 thus, patients with major depression and diabetes 
have a 36% higher risk of developing advanced microvascular 
complications, such as end stage renal disease or blindness and 
25% higher risk of developing macrovascular complications.13 
Yoshida et al,14 reported that the presence of microvascular 
complications, specifically neuropathy, was associated 
with depression independent of age, gender, marital status, 
social support, pain, perception of general health, diabetes 
type, duration of diabetes, glycated hemoglobin and insulin 
requirement. other studies have also demonstrated that presence 
of diabetic complications particularly diabetic neuropathy15 and 
retinopathy16 was associated with depression. In our study, 
depression was associated with retinopathy and neuropathy 
even after adjusting for age, gender, glycated hemoglobin and 
duration of diabetes and other microvascular complications. 
Depression has been linked with dysregulation of 
hypothalamic-pituitary-adrenal axis, over activity of the 
sympathetic nervous system and with pro-inflammatory and pro 
coagulation markers in patients with coexisting cardiovascular 
disorders.17 Studies have shown that neuro-endocrine and 
inflammatory responses accompanying depression also 
play similar roles in the progression of microvascular and 
macrovascular complications among patients with type 2 
diabetes. It is known that subjects with depression are less 
willing to start insulin therapy or take regular treatment for their 
diabetes.18 ours is a cross sectional study was based on ecG 
findings. This could also contribute to the higher HbA1c levels 
and increased risk for diabetic complications. However, in this 
study we did not find any significant difference in the HbA1c 
levels among diabetic subjects with and without depression.
Depression and ischemic heart disease are the two strongest 
contributors to the global burden of disease. An association 
between depression following acute coronary syndrome and 
subsequent adverse events like Myocardial Infarction, stroke, 
coronary heart failure and death has been observed.19 In our 
study we did not find any significant association with depression 
and coronary artery disease. Most of the earlier studies were on 
post myocardial infarction patients20 and were longitudinal in 
nature. This could explain the differences between these studies 
and the current study.
one of the limitations of our study is that, being a cross-
sectional study, definite conclusions about cause and effect 
relationships between diabetic complications and depression 
cannot be made. Secondly, depression was only measured at 
one point in time. However, this is unlikely to affect the study 
results as depression runs a chronic or recurrent course among 
patients with co-existing diabetes. Moreover these findings are 
generally consistent with those of other studies and also with 
the meta-analysis studies done by de Groot et al.2
In conclusion, this study shows that there is a significant 
association between depression and various diabetes 
complications in type 2 diabetic subjects. Although further 
research is needed to clarify the underlying mechanisms for 
this association between depression and diabetes complications, 
this study emphasizes the importance of intervening when 
patients with diabetes present with depression as treatment of 
our condition can benefit the other.
Acknowledgement
We are grateful to chennai Willingdon corporate Foundation, 
Chennai, for the financial support provided for the study. We 
thank the epidemiology team of MDRF for the fieldwork and 
most importantly the subjects who participated in the study. 
this is the 102nd paper from the cUreS study (cUreS-102).
References
1. Kinder LS, Katon WJ, Ludman e, russo J, Simon G, Lin eH et al. 
Improving depression care in patients with diabetes and multiple 
complications. J Gen Intern Med 2006;21:1036-1041.
2. de Groot M, Anderson r, Freedland Ke, clouse re, Lustman PJ. 
Association of depression and diabetes complications: a meta-
analysis. Psychosom Med 2001;63:619-630
3. carney rM, rich MW, Freedland Ke, Saini J, te Velde A, Simeone c, 
et al. Major depressive disorder predicts cardiac events in patients 
with coronary artery disease. Psychosom Med 1988;50:627-633. 
4. Sicree r, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. 
In Gan D, ed. Diabetes Atlas, 4th ed., brussels: International Diabetes 
Federation 2009;1−105.
5. Deepa M, Pradeepa r, rema M, Mohan A, Deepa r, Shanthirani 
S, et al: the chennai Urban rural epidemiology Study (cUreS) – 
Study Design and Methodology (Urban component) (cUreS-1). 
J Assoc Physicians India 2003;51:863–870.
6. Pradeepa r, rema M, Vignesh J, Deepa M, Deepa r, Mohan V. 
Prevalence and risk factors for diabetic neuropathy in an urban 
south Indian population– the chennai Urban rural epidemiology 
Study (cUreS- 55), Diabetic Medicine 2008;25:407–412.
Table 3: Association of depression with macrovascular 
complications of diabetes
Variables Odds ratio 95% confidence 
interval
p value
Peripheral Vascular Disease (No =0, Yes = 1)
Model 1: Unadjusted 3.305 1.851-5.901 <0.001
Model 2: Model 1 + age 3.560 1.974-6.419 <0.001
Model 3: Model 2 + gender 3.453 1.910-6.243 <0.001
Model 4: Model 3 + HbA1c 3.444 1.904-6.228 <0.001
Model 5: Model 4 + duration of 
diabetes
3.520 1.938-6.394 <0.001
Model 6 Model 5 + cAD 3.524 1.940-6.403 <0.001
Coronary artery disease (No =0, Yes = 1)
Model 1: Unadjusted 0.730 0.420-1.269 0.264
Model 2: Model 1 + age 0.839 0.476-1.478 0.544
Model 3: Model 2 + gender 0.835 0.474-1.472 0.534
Model 4: Model 3 + HbA1c 0.834 0.473-1.471 0.532
Model 5: Model 4 + duration of 
diabetes
0.810 0.459-1.432 0.469
Model 6:Model 5 + PVD 0.804 0.452-1.430 0.458
644  © JAPI • october 2011 • VoL. 59
7. The fifth report on the Joint National Committee on detection, 
evaluation, and treatment of  high blood pressure. Arch Intern Med 
1993;153:154–183.
8. Varghese A, Deepa r, rema M, Mohan V: Prevalence of 
microalbuminuria in type 2 diabetes mellitus at a diabetes centre 
in Southern India. Postgraduate Med J 2001;77:399–402.
9. rema M, Premkumar S, Anitha b, Deepa r, Pradeepa r, Mohan 
V. Prevalence of diabetic retinopathy in urban India: the chennai 
Urban rural epidemiology Study (cUreS) eye Study I. Investigative 
Ophthalmology and Visual Science 2005;46;2328-2333
10. early treatment Diabetic retinopathy Study research Group: 
Grading diabetic retinopathy from stereoscopic colour fundus 
photographs – an extension of the modified Airlie House 
Classification. ETDRS Report No 10. Ophthalmology 1991;98:786-806.
11. Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V. 
Prevalence and risk factors of peripheral vascular disease in a 
selected South Indian population. the chennai Urban Population 
Study (cUPS). Diabetes Care 2000;23:1295-1300.
12. Poongothai S, Pradeepa r, Ganesan A, Mohan V, reliability 
and validity of a modified PHQ- 9 item inventory (PHQ-12) as a 
screening instrument for assessing depression in Asian Indians 
(cUreS - 65). J Assoc Physicians India 2009;57:147-52.
13.  Lin EH, Heckbert SR, Rutter CM, Katon WJ, Ciechanowski P, 
Ludman EJ, Oliver M,Young BA, McCulloch DK, Von Korff M. 
Depression and Advanced complications of Diabetes: a Prospective 
cohort Study. Diabetes Care 2010;33:264-9
14. Yoshida S, Hirai M, Suzuki S, Awata S, oka Y. Neuropathy is 
associated with depression independently of health-related quality 
of life in Japanese patients with diabetes. Psychiatry Clin Neurosci 
2009;63:65-72. 
15. takahashi Y, Hirata Y. A follow-up study of painful diabetic 
neuropathy: Physical and psychological aspects. Tohoku J Exp Med 
1983;141:463–471.
16. black SA. Increased health burden associated with comorbid 
depression in older diabetic Mexican Americans. results from the 
Hispanic established Population for the epidemiologic Study of 
the elderly survey. Diabetes Care 1999;22:56–64.
17. Golden SH, Lee HB, Schreiner PJ, Roux AD, Fitzpatrick AL, Szklo 
M, et al. Depression  and type 2 diabetes mellitus: the multiethnic 
study of atherosclerosis. Psychosom Med 2007;69:529-536.
18. Makine c, Karsidag c, Kadioglu P, Ilkova H, Karsidag K, Skovlund 
Se, Snoek FJ, & PouwerF. Symptoms of depression and diabetes-
specific emotional distress are associated with a negative appraisal 
of insulin therapy in insulin-naive patients with type 2 diabetes 
mellitus. A study from the european Depression in Diabetes [eDID] 
research consortium. Diabet Med 2009;26:28-33.
19. barth, M. Schumacher and c. Herrmann-Lingen. Depression as a 
risk factor for mortality in patients with coronary heart disease: a 
meta-analysis, Psychosom Med 2004;66:802–813. 
20. Sheps DS, Freedland Ke, Golden rN et al. eNrIcHD and 
SADHArt: implications for future biobehavioral intervention 
efforts. Psychosom Med 2003;65:1–2.
